Drug Pricing
Our work in Drug Pricing
-
Cancer Mortality Reductions Were Greatest Among Countries Where Cancer Care Spending Rose The Most, 1995–2007
In this study of cancer care across 16 countries over time, the researchers found that, compared to low-spending health systems, high-spending systems had consistently lower cancer mortality.
Categorized in -
It’s Time For Value-Based Payment In Oncology
Editor’s note: This blog was first published in Health Affairs on April 28, 2015. Value-based health care has risen to the top of the health policy agenda, as public and private payers search for ways to improve outcomes. The value principle—reimbursing hospitals, physicians, and other health care providers for quality or quality improvement that also help […]
Categorized in -
Cost-Effectiveness Analysis of Alternative Screening and Treatment Strategies for Heterozygous Familial Hypercholesterolemia in the United States
Although genetic screening is currently not a cost-effective option in the US, this study found that health outcomes for individuals with familial hypercholesterolemia could benefit from adherence measures encouraging statin use.
Categorized in -
Robot-Assisted Surgery for Kidney Cancer Increased Access to a Procedure that Can Reduce Mortality and Renal Failure
This study found that the benefits of robotically assisted surgery for patients with kidney cancer outweigh the healthcare and surgical costs by a ratio of 5 to 1.
Categorized in -
Benefits of Robotic-Assisted Surgery for Kidney Cancer Far Outweigh Investment Costs
The benefits of robotically-assisted surgery for patients with kidney cancer outweigh the healthcare and surgical costs by a ratio of five to one. This is according to new research published in Health Affairs this week.
Categorized in -
Making Health Care Affordable: What’s Driving Costs?
Geoffrey Joyce provided expert testimony to the California Senate Health Committee about the role of the biomedical industry in healthcare cost trends.
-
Understanding Data Requirements of Retrospective Studies
This study characterize the types and patterns of data usage from electronic health records for clinical research.
Categorized in -
Biomedical Research in the Age of Preventive Medicine
The exceptional value of delayed aging comes from a re-alignment of medical research and innovation with the health challenges of an aging population.
Categorized in -
Estimates of Utility Weights in Hemophilia: Implications for Cost-Utility Analysis of Clotting Factor Prophylaxis
This study assesses the cost-effectiveness of prophylactic use of clotting factor compared with on-demand treatment among people with hemophilia.
Categorized in -
SimCoach Evaluation: A Virtual Human Intervention to Encourage Service-Member Help-Seeking for Posttraumatic Stress Disorder and Depression
This report describes RAND Corporation researchers’ assessment of SimCoach, a computer program featuring a virtual human that speaks and gestures in a video game-like interface, designed to encourage service members, especially those with signs or symptoms of posttraumatic stress disorder or depression, to seek help to improve their psychological health, and found that, if SimCoach development is continued, greater attention to clinical processes and outcomes is needed so that the program can have its intended impact.
Categorized in